Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in Israel
6 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).
- Where
- Beersheba, Jerusalem, Tel Aviv
- Age
- 18 years and over
- People
- 380 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07722611 · EU 2026-525630-38-00 - Phase 3Not yet taking people in IsraelA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv
- Age
- 18 years and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - Phase 1Taking peopleA Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Where
- Haifa, Jerusalem, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06150157 · EU 2023-505584-36-00 - Phase 3CompletedA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Afula, Haifa, Jerusalem, Nahariya, Petah Tikva
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - Phase 3Taking peopleStudy on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Haifa, Jerusalem, Tel Aviv
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672 · EU 2022-502276-23-00 - Phase 2Taking peopleA Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Where
- Haifa, Tel Aviv
- Age
- 18 years and over
- People
- 58 worldwide
- Run by
- Karyopharm Therapeutics Inc
See details and how to joinNCT05980806